Qiuling Ma

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Performance validation of mass spectrometry for detecting urinary Bence Jones protein and evaluation of its clinical application in multiple myeloma and amyloidosis.

Performance validation of mass spectrometry for detecting urinary Bence Jones protein and evaluation of its clinical application in multiple myeloma and amyloidosis.

Journal: Clinical chemistry and laboratory medicine

Published: March 25, 2026

Integrated one-pot RPA-CRISPR/Cas13a platform enables ultrasensitive and field-deployable JAK2 V617F detection for myeloproliferative neoplasm diagnosis.

Integrated one-pot RPA-CRISPR/Cas13a platform enables ultrasensitive and field-deployable JAK2 V617F detection for myeloproliferative neoplasm diagnosis.

Journal: Journal of pharmaceutical and biomedical analysis

Published: July 27, 2025

Quercetin inhibits the cAMP/PKA/CREB/glycolysis axis to exert anti-acute lymphoblastic leukemia effects.

Quercetin inhibits the cAMP/PKA/CREB/glycolysis axis to exert anti-acute lymphoblastic leukemia effects.

Journal: Frontiers in pharmacology

Published: April 20, 2025

A bi-specific CAR-T cell therapy targeting CD19 and CD22 in relapsed or refractory B-ALL.

A bi-specific CAR-T cell therapy targeting CD19 and CD22 in relapsed or refractory B-ALL.

Journal: Clinical and experimental medicine

Published: January 05, 2025

Efficacy and safety of telitacicept in patients with class III-V lupus nephritis: A real-world retrospective cohort study.

Efficacy and safety of telitacicept in patients with class III-V lupus nephritis: A real-world retrospective cohort study.

Journal: International immunopharmacology

Published: December 27, 2024

Anti-BCMA CAR-T therapy for multiple myeloma with extramedullary disease: A case report and review of the literature.

Anti-BCMA CAR-T therapy for multiple myeloma with extramedullary disease: A case report and review of the literature.

Journal: Medicine

Published: June 28, 2024

Hsa_circ_0007099 and PIP4K2A coexpressed in diffuse large B-cell lymphoma with clinical significance.

Hsa_circ_0007099 and PIP4K2A coexpressed in diffuse large B-cell lymphoma with clinical significance.

Journal: Genes & diseases

Published: May 05, 2023

Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis.

Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis.

Journal: European journal of medical research

Published: November 18, 2022

CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status.

CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status.

Journal: American journal of hematology

Published: December 26, 2021

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia.

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia.

Journal: Journal of translational medicine

Published: February 28, 2019

In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia.

In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 02, 2017

Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.

Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.

Journal: Scientific reports

Published: September 16, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026